D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate

2004 ◽  
Vol 36 (05) ◽  
Author(s):  
J Scherer ◽  
M Albus ◽  
H Förstl ◽  
T Jahn ◽  
T Mager ◽  
...  
Keyword(s):  
Dopamine Receptor ◽  
D2 Receptor ◽  
Receptor Occupancy ◽  
D2 Dopamine Receptor ◽  
Haloperidol Decanoate ◽  
Flupentixol Decanoate

D2-dopamine-receptor occupancy during treatment with haloperidol decanoate

1997 ◽  
Vol 247 (2) ◽  
pp. 104-106
Author(s):  
Josef Scherer ◽  
Klaus Tatsch ◽  
Margot Albus ◽  
Johannes Schwarz ◽  
Torsten Mager ◽  
...  
Keyword(s):  
Dopamine Receptor ◽  
Receptor Occupancy ◽  
D2 Dopamine Receptor ◽  
Haloperidol Decanoate

D1- and D2-dopamine receptor occupancy during treatment with classical and atypical neurpleptics

1990 ◽  
Vol 3 (1) ◽  
pp. 51-52
Author(s):  
L. Farde ◽  
A.-L. Nordstrom ◽  
F.-A. Wiesel ◽  
C. Halldin ◽  
G. Sedvall
Keyword(s):  
Dopamine Receptor ◽  
Receptor Occupancy ◽  
D2 Dopamine Receptor

Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findings

NeuroImage ◽  
2003 ◽  
Vol 19 (3) ◽  
pp. 1205-1214 ◽  
Author(s):  
Kjell Erlandsson ◽  
Rodrigo A. Bressan ◽  
Rachel S. Mulligan ◽  
Peter J. Ell ◽  
Vincent J. Cunningham ◽  
...  
Keyword(s):  
Dopamine Receptor ◽  
Receptor Occupancy ◽  
D2 Dopamine Receptor ◽  
High Affinity ◽  
Affinity Ligand ◽  
High Affinity Ligand
Sign in / Sign up

Export Citation Format

Share Document